222 related articles for article (PubMed ID: 34403710)
1. Methotrexate use and liver outcomes in psoriasis and rheumatoid arthritis patients: A commentary on "Risk of liver disease in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis receiving methotrexate: A population-based study".
Gau SY
J Am Acad Dermatol; 2021 Dec; 85(6):e399-e400. PubMed ID: 34403710
[No Abstract] [Full Text] [Related]
2. Response to: "Methotrexate Use and Liver Outcomes in Psoriasis and Rheumatoid Arthritis Patients: A Commentary on 'Risk of liver disease in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis receiving methotrexate: A population-based study'".
Gelfand JM; Syed MN
J Am Acad Dermatol; 2021 Dec; 85(6):e401. PubMed ID: 34403717
[No Abstract] [Full Text] [Related]
3. Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study.
Gelfand JM; Wan J; Zhang H; Shin DB; Ogdie A; Syed MN; Egeberg A
J Am Acad Dermatol; 2021 Jun; 84(6):1636-1643. PubMed ID: 33607181
[TBL] [Abstract][Full Text] [Related]
4. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362
[TBL] [Abstract][Full Text] [Related]
5. Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study.
Ogdie A; Grewal SK; Noe MH; Shin DB; Takeshita J; Chiesa Fuxench ZC; Carr RM; Gelfand JM
J Invest Dermatol; 2018 Apr; 138(4):760-767. PubMed ID: 29104161
[TBL] [Abstract][Full Text] [Related]
6. Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.
Chen YJ; Chang YT; Shen JL; Chen TT; Wang CB; Chen CM; Wu CY
Arthritis Rheum; 2012 Jun; 64(6):1879-87. PubMed ID: 22161801
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Methotrexate for Chinese Adults With Psoriasis With and Without Psoriatic Arthritis.
Yan K; Zhang Y; Han L; Huang Q; Zhang Z; Fang X; Zheng Z; Yawalkar N; Chang Y; Zhang Q; Jin L; Qian D; Li X; Wu M; Xu Q; Zhang X; Xu J
JAMA Dermatol; 2019 Mar; 155(3):327-334. PubMed ID: 30698628
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis.
Radner H; Lesperance T; Accortt NA; Solomon DH
Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1510-1518. PubMed ID: 27998029
[TBL] [Abstract][Full Text] [Related]
9. Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection.
Rokhsar C; Rabhan N; Cohen SR
J Am Acad Dermatol; 2006 Feb; 54(2):361-2. PubMed ID: 16443079
[No Abstract] [Full Text] [Related]
10. Comment on: Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
Lynch M; Kirby B
Rheumatology (Oxford); 2010 Jan; 49(1):196-7; author reply 197-8. PubMed ID: 19858119
[No Abstract] [Full Text] [Related]
11. [Experience with long term low dose methotrexate treatment in rheumatoid arthritis and arthritic psoriasis].
Náfrádi L; Varga L
Orv Hetil; 1995 Jul; 136(29):1555-7. PubMed ID: 7637973
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate use in psoriasis and psoriatic arthritis.
Cuellar ML; Espinoza LR
Rheum Dis Clin North Am; 1997 Nov; 23(4):797-809. PubMed ID: 9361156
[TBL] [Abstract][Full Text] [Related]
13. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
Lanse SB; Arnold GL; Gowans JD; Kaplan MM
Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
[TBL] [Abstract][Full Text] [Related]
14. The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.
Gordon KB; Ruderman EM
J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S85-91. PubMed ID: 16488334
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate and liver toxicity: role of surveillance liver biopsy. Conflict between guidelines for rheumatologists and dermatologists.
Hassan W
Ann Rheum Dis; 1996 May; 55(5):273-5. PubMed ID: 8660097
[No Abstract] [Full Text] [Related]
16. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.
Armstrong AW; Brezinski EA; Follansbee MR; Armstrong EJ
Curr Pharm Des; 2014; 20(4):500-12. PubMed ID: 23565631
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study.
Grellmann C; Dombrowsky W; Fabricius V; Suruki R; Sheahan A; Joeres L
Adv Ther; 2021 Jan; 38(1):366-385. PubMed ID: 33128201
[TBL] [Abstract][Full Text] [Related]
18. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
Zachariae H; Aslam HM; Bjerring P; Søgaard H; Zachariae E; Heickendorff L
J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
[TBL] [Abstract][Full Text] [Related]
19. A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn's disease receiving methotrexate therapy.
Cervoni JP; Alby-Lepresle B; Weil D; Zhong P; Aubin F; Wendling D; Toussirot E; Vuitton L; Carbonnel F; Blondet R; Thévenot T; Calès P; Monnet E; Di Martino V
Clin Res Hepatol Gastroenterol; 2020; 44S():100003. PubMed ID: 33602481
[TBL] [Abstract][Full Text] [Related]
20. Total cholesterol, lipoprotein, and triglyceride levels in tumor necrosis factor inhibitor-treated patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis.
Wu JJ; Rowan CG; Bebchuk JD; Anthony MS
Int J Dermatol; 2015 Oct; 54(10):e442-5. PubMed ID: 26234307
[No Abstract] [Full Text] [Related]
[Next] [New Search]
